Activation and self-tolerance of natural killer cells

被引:154
作者
Gasser, Stephan
Raulet, David H.
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA
关键词
DNA damage response; hyporesponsiveness; innate immunity; natural killer cells; tolerance; tumor immunology;
D O I
10.1111/j.1600-065X.2006.00460.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells are regulated by numerous stimulatory and inhibitory receptors that recognize various classes of cell surface ligands, some of which are expressed by normal healthy cells. We review two key issues in NK cell biology. How do NK cells achieve tolerance to healthy self-cells, despite great potential variability in inhibitory and stimulatory receptor engagement? How is the disease status of unhealthy cells translated into changes in ligand expression and consequent sensitivity to NK cell lysis? Concerning the second question, we review evidence that ligands for one key NK receptor, NKG2D, are induced by the DNA damage response, which is activated in cells exposed to genotoxic stress. Because cancer cells and some infected cells are subject to genotoxic stress, these findings suggest a new concept for how diseased cells are discriminated by the immune system. Second, we review studies that have overturned the prevalent notion that NK cells achieve self-tolerance by expressing inhibitory receptors specific for self-major histocompatibility complex class I molecules. A subset of NK cells lacks such receptors. These NK cells are hyporesponsive when stimulatory receptors are engaged, suggesting that alterations in signaling pathways that dampen stimulatory receptor signals contribute to self-tolerance of NK cells.
引用
收藏
页码:130 / 142
页数:13
相关论文
共 113 条
[91]   NKG2D function protects the host from tumor initiation [J].
Smyth, MJ ;
Swann, J ;
Cretney, E ;
Zerafa, N ;
Yokoyama, WM ;
Hayakawa, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) :583-588
[92]   Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors [J].
Stewart, CA ;
Laugier-Anfossi, F ;
Vély, F ;
Saulquin, X ;
Riedmuller, J ;
Tisserant, A ;
Gauthier, L ;
Romagné, F ;
Ferracci, G ;
Arosa, FA ;
Moretta, A ;
Sun, PD ;
Ugolini, S ;
Vivier, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (37) :13224-13229
[93]   UL16-Binding proteins, novel MHC class I-Related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells [J].
Sutherland, CL ;
Chalupny, NJ ;
Schooley, K ;
VandenBos, T ;
Cosman, D .
JOURNAL OF IMMUNOLOGY, 2002, 168 (02) :671-679
[94]   Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules [J].
Tanamachi, DM ;
Hanke, T ;
Takizawa, H ;
Jamieson, AM ;
Raulet, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (03) :307-315
[95]   BIOLOGY OF NATURAL-KILLER CELLS [J].
TRINCHIERI, G .
ADVANCES IN IMMUNOLOGY, 1989, 47 :187-376
[96]   Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response [J].
Unanue, ER .
IMMUNOLOGICAL REVIEWS, 1997, 158 :11-25
[97]   Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors [J].
Valiante, NM ;
Uhrberg, M ;
Shilling, HG ;
Lienert-Weidenbach, K ;
Arnett, KL ;
D'Andrea, A ;
Phillips, JH ;
Lanier, LL ;
Parham, P .
IMMUNITY, 1997, 7 (06) :739-751
[98]   Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b [J].
Vance, RE ;
Kraft, JR ;
Altman, JD ;
Jensen, PE ;
Raulet, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1841-1848
[99]   MOLECULAR CLONES OF THE P58 NK CELL-RECEPTOR REVEAL IMMUNOGLOBULIN-RELATED MOLECULES WITH DIVERSITY IN BOTH THE EXTRACELLULAR AND INTRACELLULAR DOMAINS [J].
WAGTMANN, N ;
BIASSONI, R ;
CANTONI, C ;
VERDIANI, S ;
MALNATI, MS ;
VITALE, M ;
BOTTINO, C ;
MORETTA, L ;
MORETTA, A ;
LONG, EO .
IMMUNITY, 1995, 2 (05) :439-449
[100]   Proteolytic release of soluble UL16-binding protein 2 from tumor cells [J].
Waldhauer, I ;
Steinle, A .
CANCER RESEARCH, 2006, 66 (05) :2520-2526